190 related articles for article (PubMed ID: 22188725)
1. Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells.
Napoleone E; Cutrone A; Cugino D; Amore C; Di Santo A; Iacoviello L; de Gaetano G; Donati MB; Lorenzet R
Thromb Res; 2012 Jun; 129(6):736-42. PubMed ID: 22188725
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer.
Chen X; Meng Q; Zhao Y; Liu M; Li D; Yang Y; Sun L; Sui G; Cai L; Dong X
Cancer Lett; 2013 Jan; 328(2):318-24. PubMed ID: 23092556
[TBL] [Abstract][Full Text] [Related]
4. Anti-tissue factor short hairpin RNA inhibits breast cancer growth in vivo.
Bluff JE; Amarzguioui M; Slattery J; Reed MW; Brown NJ; Staton CA
Breast Cancer Res Treat; 2011 Aug; 128(3):691-701. PubMed ID: 20830515
[TBL] [Abstract][Full Text] [Related]
5. Aliskiren, a renin inhibitor, downregulates TNF-α-induced tissue factor expression in HUVECS.
Del Fiorentino A; Cianchetti S; Celi A; Pedrinelli R
J Renin Angiotensin Aldosterone Syst; 2010 Dec; 11(4):243-7. PubMed ID: 20798130
[TBL] [Abstract][Full Text] [Related]
6. Leptin upregulates tissue factor expression in human breast cancer MCF-7 cells.
Napoleone E; Cutrone A; Cugino D; Latella MC; Zurlo F; Iacoviello L; de Gaetano G; Donati MB; Lorenzet R
Thromb Res; 2012 May; 129(5):641-7. PubMed ID: 21840575
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes.
He M; He X; Xie Q; Chen F; He S
Thromb Res; 2006; 117(5):579-90. PubMed ID: 15953627
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
9. High glucose potentiates and renin-angiotensin blockade downregulates LPS-induced tissue factor expression in human mononuclear cells.
Balia C; Petrini S; Cordazzo C; Cianchetti S; Neri T; Celi A; Pedrinelli R
Thromb Res; 2012 Sep; 130(3):552-6. PubMed ID: 22817879
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel downregulates tissue factor in cancer and host tumour-associated cells.
Napoleone E; Zurlo F; Latella MC; Amore C; Di Santo A; Iacoviello L; Donati MB; Lorenzet R
Eur J Cancer; 2009 Feb; 45(3):470-7. PubMed ID: 19046877
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of the renin-angiotensin system can counteract cardiac angiogenic vascular endothelial growth factor gene therapy and myocardial angiogenesis in the normal heart.
Siddiqui AJ; Mansson-Broberg A; Gustafsson T; Grinnemo KH; Dellgren G; Hao X; Fischer H; Sylvén C
Am J Hypertens; 2005 Oct; 18(10):1347-52. PubMed ID: 16202860
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
13. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
14. Effects of human breast stromal cells on conjugated linoleic acid (CLA) modulated vascular endothelial growth factor-A (VEGF-A) expression in MCF-7 cells.
Wang LS; Huang YW; Sugimoto Y; Liu S; Chang HL; Ye W; Shu S; Lin YC
Anticancer Res; 2005; 25(6B):4061-8. PubMed ID: 16312046
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
De Godoy MA; Rattan S
J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes.
Napoleone E; Di Santo A; Camera M; Tremoli E; Lorenzet R
Circ Res; 2000 Feb; 86(2):139-43. PubMed ID: 10666408
[TBL] [Abstract][Full Text] [Related]
17. The renin-angiotensin system in the breast and breast cancer.
Vinson GP; Barker S; Puddefoot JR
Endocr Relat Cancer; 2012 Feb; 19(1):R1-19. PubMed ID: 22180497
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells.
Yoshiji H; Yoshii J; Ikenaka Y; Noguchi R; Yanase K; Tsujinoue H; Imazu H; Fukui H
Int J Oncol; 2002 Jun; 20(6):1227-31. PubMed ID: 12012003
[TBL] [Abstract][Full Text] [Related]
19. Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer.
Herr D; Rodewald M; Fraser HM; Hack G; Konrad R; Kreienberg R; Wulff C
Gynecol Oncol; 2008 Jun; 109(3):418-25. PubMed ID: 18395779
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system (RAS) blockade attenuates growth and metastatic potential of renal cell carcinoma in mice.
Araújo WF; Naves MA; Ravanini JN; Schor N; Teixeira VP
Urol Oncol; 2015 Sep; 33(9):389.e1-7. PubMed ID: 25595575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
